Galunisertib : A TGFβ Signaling Inhibitor, SB431542, Inhibits Reovirus-mediated Lysis of Human Hepatocellular Carcinoma Cells in a TGFβ-independent Manner

PF-03084014 : Capturing Patient Voice to Improve Outcomes That Matter to Patients with Desmoid Tumor